|
Jackson Heart Study (JHS) Clinical Trials Data presented on Clinical Trials Search is not meant to be a substitute for qualified medical advice, visits or professional assistance with a genuine dr.. We are not doctors. Always consult your mD about Jackson Heart Study (JHS) conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Jackson Heart Study (JHS) Clinical research trials and Jackson Heart Study (JHS) medical trials take place in many of places throughout the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the effectiveness of new does drugs. The purpose of the studies / projects is to solve specific human healthcare questions. Clinical trials are a popular way for mDs, government agencies, and private sector companies to find cures for all varieties of conditions, like Jackson Heart Study (JHS). Jackson Heart Study (JHS) Clinical Trials and other clinical trials allow for volunteers to have health treatment options before they are available to the masses. Many times the human subjects acquire professional assistance for free of charge, and sometimes they are compensated for their time. Occasionally there is a cost for a Jackson Heart Study (JHS) clinical trial. Test subjects typically obtain the finest healthcare available for their Jackson Heart Study (JHS) condition. Dangers are a reality, nevertheless, and might include additional or frequent doctor trips, medical dangers (possibly life-jeopardising), and/or the treatment being ineffectual. Trials are federally regulated with strict guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "J" Clinical Trials Conditions > Jackson Heart Study (JHS)  Jackson Heart Study (JHS)
Jackson Heart Study (JHS)
For Condition: Atherosclerosis,Coronary Disease,Cerebrovascular Disorders,Cardiovascular Diseases,Heart Diseases,Hypertension
Status: Recruiting
Sponsor(s): National Heart, Lung, and Blood Institute (NHLBI) , National Center on Minority Health and Health Disparities (NCMHD)
Synopsis: To conduct a prospective study of the environmental and genetic factors influencing the development of cardiovascular disease in African American men and women. The cohort is an expansion of the Jackson, Mississippi site of the Atherosclerosis Risk in Communities (ARIC) study and is a partnership among two minority institutions (Jackson State University, Tougaloo College), and one majority institution in Jackson, Mississippi (the University of Mississippi Medical Center), and the NIH National Center on Minority Health and Health Disparities (NCMHD) and the National Heart, Lung, and Blood Institute (NHLBI).
Details: BACKGROUND: Heart disease and stroke remain the first and third leading killers of all Americans, with a disproportionate share of the burden borne by African Americans. Cardiovascular and total mortality are known to be higher in Black than white Americans, but reasons for these differences remain to be defined. In addition, well-documented declines in cardiovascular and coronary disease mortality in the past three decades have not been shared equally between Blacks and whites; age-adjusted death rates were identical in both groups in 1980, but by 1994 the rate among African Americans was 14 percent higher than in whites. The race difference in magnitude of coronary heart disease (CHD) mortality is greater in women than men and higher in middle age, so that CHD deaths tend to occur in Blacks about five years earlier than in whites. Excess cerebrovascular disease incidence and mortality in Blacks are even greater than the differences noted in CHD. Cardiovascular mortality rates in Mississippi are the highest in the United States for all race-sex groups and are approximately 25 percent higher than the United States average. Age-adjusted CVD mortality for African American women in Mississippi was 75 percent higher than in white women in 1994, and for African American men was 47 percent higher than in white men. Prevalence of hypertension is nearly 40 percent greater in African Americans than whites and its sequelae are more frequent and severe. Evidence of target organ damage such as renal failure and left ventricular hypertropy is more common in Black than white hypertensives at comparable levels of blood pressure. Many other risk factors are also more common in Blacks, including diabetes, Lp(a) and obesity (in women) while others such as elevated total cholesterol, reduced HDL-cholesterol and heavy cigarette smoking are more common in whites. DESIGN NARRATIVE: The Jackson Heart Study (JHS), an Institute-initiated prospective study of the environmental and genetic factors influencing the development of cardiovascular disease (CVD) in African-Americans, is sponsored by the National Heart, Lung, and Blood Institute (NHLBI) and the National Center on Minority Health and Health Disparities (NCMHD) of the National Institutes of Health. The Jackson Heart Study initial examination began in the fall of 2000, will include 6,500 men and women aged 35-84 and will take three years to complete. The study is a partnership among NHLBI, NCMHD, and three local institutions: Jackson State University, Tougaloo College and the University of Mississippi Medical Center. The Coordinating Center, located at Jackson State University, will collect and analyze data. The Undergraduate Training Center at Tougaloo College will offer coursework to students in public health and epidemiology and provide practical experience in health research to prepare them for potential careers in these fields. The Exam Center at the University of Mississippi is responsible for recruiting participants and conducting the examinations. By incorporating state-of-the-art physiologic and epidemiologic methods in a stable population-based minority cohort, providing research experience, and building research capabilities at minority institutions, the Jackson Heart Study is uniquely positioned to answer key questions regarding the excess burden of CVD among African-Americans and to address the critical shortage of minority investigators trained in epidemiology and prevention.
Eligibility:
Study Type: Observational, Natural History
Minimum Age/Maximum Age: 35 Years/84 Years
Genders: Both
Protocol Entry Criteria: No eligibility criteria
Total Enrollment:
Location and Contact Information:
Overall Study Official:
AsokaSrinivasan, , Tougaloo College
University of Mississippi Medical Center *Recruiting*
Jackson, Mississippi, 39213
United States
Recruiting Dr. W. Taylor 601-984-5630
Additional Information:
Study ID Numbers: 5001;
Study Start Date: October 1996
Record last reviewed: May 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00005485
Other Atherosclerosis Studies:
1. The Role of Angiotensin Type I Receptor in the Regulation of Human Coronary Vascular Function
2. Insulin Resistance Atherosclerosis Study (IRAS)
3. Multi-Ethnic Study of Atherosclerosis (MESA)
4. Longitudinal LDL-C Studies in Black and White Families
5. Risk Factors for CV Disease in a Dialysis Cohort
Related Studies:
Other Atherosclerosis Clinical Trials
Other Mississippi Clinical Trials
Other Jackson Clinical Trials
Jackson Heart Study (JHS)
|
|
|
|
|
|
|
|
